Business Insider

Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in ...

CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
The Guardian

Datacentres using 6% of electricity supply in UK and US, research says

Industry body says energy consumption driven by AI up 15% globally in two years as it warns of societal backlash Datacentres are consuming 6% of electricity in the UK and US, with the growing strain ...
Barron's

Beam Therapeutics Inc.

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem ...
ascopubs.org

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort

Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor ...
UNHCR

Forced displacement flow dataset

UNHCR has published a new dataset recording the number of people forced to flee during each of the years since 1962. This dataset presents the forced displacement flows. Stocks and flows Commonly ...